crosgram.blogg.se

New findings pose tough questions children
New findings pose tough questions children






new findings pose tough questions children

The doses may not have roused an adequate response. Children aged 5 to 11 received 10 micrograms, and those 6 months to 5 years old received just three. The same dose was given to adolescents in the Pfizer trials. The vaccines made by Moderna and Johnson are only for adults. The Pfizer-BioNTech vaccine is the only one authorized for children. The trials in children were complicated by the arrival of the Delta and Omicron variant, and the vaccine appeared to be less protective in young children. The Pfizer-BioNTech and Moderna vaccines were quickly authorized for use after they proved to be safe and powerfully protective in clinical trials. In the trials in adults in 2020, vaccine manufacturers made best guesses at the right dose and opted for short intervals between the shots to protect people as quickly as possible during the initial surge. The studies suggest that the problem is not the vaccine but the dose. Image At the moment, the Pfizer-BioNTech vaccine is the only one authorized for children, whose dose is 10 micrograms for children ages 5 to 11 and three micrograms for children under age 5. James Campbell is a physician at the University of Maryland School of Medicine and a member of the American Academy of Pediatrics committee on infectious diseases.Įvery single one of his sick children was unvaccinated, according to Dr. She said that the best protection for children is to have had at least two shots before the fall or winter season.Įven with the Omicron variant, the vaccines are still preventing disease and death. Luciana Borio is a former acting chief scientist at the Food and Drug Administration. The most recent findings make it more difficult to convince some parents to immunize their children. According to recent data from the C.D.C, as much as 95 percent of the country has some degree of protection from the virus because of vaccines or prior infections. The balance of risk and benefit was never the same for children and adults. In the United States, those percentages are even lower. Only a small percentage of adolescents have received a booster dose of the vaccine. Less than one in four children are fully protected. Thomas for The New York TimesĪs the Omicron variant fades in the United States, it will be difficult for parents to decide whether to vaccine their children. Louis. “The part that’s confusing is like there’s no longer any clear, right answer,” said Ms. Image Anne Gonzalez with her children Ezra, 10, left, and Alaya, 7, in St. If the results are positive, there will be a new round of regulatory review that may allow for tens of millions of vaccinations. Pfizer and Moderna will report the results of their vaccine trials. The coming weeks will bring some clarity. Who could blame parents for not knowing what to do?Īnne Gonzalez is a 41-year-old mother of two who manages volunteers for a large religious nonprofit. The agency said that 90 percent of Americans can stop wearing masks in public indoor spaces, even in schools with young children. The need for vaccines for children under the age of 5 was underscored by the record number of children hospitalized during the Omicron surge. While the Omicron variant may be able to penetrate immune defenses and cause illness, the vaccines still prevent severe illness and death, and may do so for years. On Monday, Florida's surgeon general declared that healthy children don't need to be immunized, advice that Jen Psaki, the White House press secretary, called deeply disturbing.

new findings pose tough questions children

The vaccine was only weakly protective against infections with the Omicron variant among children aged 5 to 11 and it appeared to offer little defense against moderate Covid illness among adolescents aged 12 to 17. The vaccine for the youngest children was scrapped 10 days later because of doubts about its effectiveness. Do not duplicate in any form without permission.The last couple of months have been difficult for American parents with young children.








New findings pose tough questions children